Valley National Advisers’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $586K | Sell |
6,769
-7
| -0.1% | -$671 | 0.08% | 165 |
|
|
2025
Q4 | $650K | Sell |
6,776
-111
| -2% | -$10.8K | 0.09% | 156 |
|
|
2025
Q3 | $655K | Sell |
6,887
-13
| -0.2% | -$1.2K | 0.1% | 153 |
|
|
2025
Q2 | $601K | Sell |
6,900
-1,736
| -20% | -$147K | 0.1% | 156 |
|
|
2025
Q1 | $776K | Sell |
8,636
-18,481
| -68% | -$1.65M | 0.14% | 138 |
|
|
2024
Q4 | $2.17M | Sell |
27,117
-7,370
| -21% | -$638K | 0.39% | 63 |
|
|
2024
Q3 | $3.1M | Sell |
34,487
-47,024
| -58% | -$3.96M | 0.56% | 40 |
|
|
2024
Q2 | $6.42M | Sell |
81,511
-5,375
| -6% | -$441K | 0.95% | 22 |
|
|
2024
Q1 | $7.57M | Buy |
86,886
+11,029
| +15% | +$941K | 1.14% | 20 |
|
|
2023
Q4 | $6.25M | Buy |
75,857
+3,097
| +4% | +$236K | 0.99% | 24 |
|
|
2023
Q3 | $5.7M | Buy |
72,760
+17,394
| +31% | +$1.46M | 1% | 22 |
|
|
2023
Q2 | $4.88M | Sell |
55,366
-381
| -0.7% | -$32.8K | 0.82% | 27 |
|
|
2023
Q1 | $5M | Buy |
55,747
+1,635
| +3% | +$133K | 0.88% | 25 |
|
|
2022
Q4 | $4.35M | Sell |
54,112
-8,245
| -13% | -$668K | 0.78% | 32 |
|
|
2022
Q3 | $5.24M | Sell |
62,357
-1,304
| -2% | -$117K | 1.09% | 19 |
|
|
2022
Q2 | $5.7M | Buy |
63,661
+4,707
| +8% | +$477K | 1.2% | 17 |
|
|
2022
Q1 | $6.54M | Buy |
58,954
+14,101
| +31% | +$1.49M | 1.25% | 17 |
|
|
2021
Q4 | $4.64M | Buy |
44,853
+32,401
| +260% | +$3.75M | 0.86% | 22 |
|
|
2021
Q3 | $1.56M | Buy |
12,452
+942
| +8% | +$122K | 0.28% | 88 |
|
|
2021
Q2 | $1.43M | Sell |
11,510
-47
| -0.4% | -$5.9K | 0.26% | 91 |
|
|
2021
Q1 | $1.36M | Sell |
11,557
-62
| -0.5% | -$7.27K | 0.27% | 91 |
|
|
2020
Q4 | $1.36M | Buy |
11,619
+2,390
| +26% | +$263K | 0.29% | 68 |
|
|
2020
Q3 | $959K | Sell |
9,229
-604
| -6% | -$60.7K | 0.22% | 75 |
|
|
2020
Q2 | $902K | Sell |
9,833
-205
| -2% | -$19.7K | 0.21% | 81 |
|
|
2020
Q1 | $905K | Sell |
10,038
-26
| -0.3% | -$2.77K | 0.25% | 74 |
|
|
2019
Q4 | $1.14M | Buy |
10,064
+86
| +0.9% | +$9.44K | 0.29% | 71 |
|
|
2019
Q3 | $1.08M | Buy |
9,978
+286
| +3% | +$29.8K | 0.3% | 69 |
|
|
2019
Q2 | $944K | Buy |
9,692
+200
| +2% | +$18.3K | 0.26% | 75 |
|
|
2019
Q1 | $865K | Buy |
9,492
+2,632
| +38% | +$236K | 0.25% | 77 |
|
|
2018
Q4 | $624K | Buy |
6,860
+1,293
| +23% | +$121K | 0.2% | 93 |
|
|
2018
Q3 | $548K | Buy |
5,567
+2,228
| +67% | +$206K | 0.19% | 108 |
|
|
2018
Q2 | $286K | Buy |
3,339
+2,358
| +240% | +$197K | 0.11% | 148 |
|
|
2018
Q1 | $79K | Buy |
981
+475
| +94% | +$39.2K | 0.03% | 221 |
|
|
2017
Q4 | $41K | Sell |
506
-500
| -50% | -$40K | 0.01% | 266 |
|
|
2017
Q3 | $78K | Buy |
1,006
+60
| +6% | +$4.98K | 0.03% | 216 |
|
|
2017
Q2 | $84K | Buy |
946
+500
| +112% | +$42.2K | 0.03% | 207 |
|
|
2017
Q1 | $36K | Buy |
446
+306
| +219% | +$23.9K | 0.01% | 270 |
|
|
2016
Q4 | $10K | Hold |
140
| – | – | ﹤0.01% | 406 |
|
|
2016
Q3 | $12K | Hold |
140
| – | – | 0.01% | 359 |
|
|
2016
Q2 | $12K | Hold |
140
| – | – | 0.01% | 366 |
|
|
2016
Q1 | $11K | Buy |
140
+1
| +0.7% | +$75 | 0.01% | 371 |
|
|
2015
Q4 | $11K | Hold |
139
| – | – | 0.01% | 366 |
|
|
2015
Q3 | $9K | Hold |
139
| – | – | 0.01% | 393 |
|
|
2015
Q2 | $10K | Hold |
139
| – | – | 0.01% | 381 |
|
|
2015
Q1 | $11K | Buy |
139
+94
| +209% | +$7.13K | 0.01% | 374 |
|
|
2014
Q4 | $3K | Buy |
+45
| New | +$3.13K | ﹤0.01% | 365 |
|
Other funds holding MDT
VCM
VPM
Valley National Advisers's MDT Position: Q1 2026 in Review
Valley National Advisers reduced its Medtronic (MDT) stake by 0.1% in Q1 2026, selling an estimated $671 and leaving 6,769 shares worth $586K. The position accounts for 0.08% of the portfolio, ranked #165.
Valley National Advisers first reported a position in MDT in Q4 2014 and has held it in 46 quarters since. The position peaked at $7.57M in Q1 2024. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Valley National Advisers held 6,769 shares of Medtronic worth $586K as of Q1 2026.
- Valley National Advisers sold 7 Medtronic shares in Q1 2026, an estimated $671.
- Medtronic made up 0.08% of Valley National Advisers's portfolio in Q1 2026, its #165 holding.
- Valley National Advisers first reported a position in Medtronic in Q4 2014 and has held it in 46 quarters since.
- Valley National Advisers's Medtronic position peaked at $7.57M in Q1 2024.
- 2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Valley National Advisers's 13F filing for Q1 2026, filed 15 Apr 2026.